Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder cancer

H Ozen1

  • 1Hacettepe University, Department of Urology, Ankara, Turkey.

Current Opinion in Oncology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Transitional cell carcinomas (TCCs) are diverse, with invasive forms having poor prognoses. Identifying genetic changes in superficial TCCs is crucial for predicting progression and guiding therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new adjacent tool in the management of clinical T1a solid renal masses.

Actas urologicas espanolas·2026
Same author

Neutrophil volume distribution width as a new marker in detecting inflammatory bowel disease activation.

International journal of laboratory hematology·2016
Same author

Successful outcome with second hematopoietic stem cell transplantation in a patient with IL-10R deficiency.

Bone marrow transplantation·2015
Same author

Is routine stenting necessary in pyeloplasty?

Pediatric surgery international·2013
Same author

Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?

Indian journal of urology : IJU : journal of the Urological Society of India·2010
Same author

Pathological, biochemical and haematological investigations on the protective effect of alpha-lipoic acid in experimental aflatoxin toxicosis in chicks.

British poultry science·2010
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transitional cell carcinomas (TCCs) present as heterogeneous neoplasms with varying clinical outcomes.
  • Superficial TCCs generally have good prognoses with local treatment, but a subset (20%) can progress to muscle-invasive disease.
  • Identifying patients at risk for progression and tumors responsive to therapy remains a clinical challenge.

Purpose of the Study:

  • To explore the role of genetic alterations in understanding the heterogeneity of transitional cell carcinomas.
  • To identify molecular markers that can distinguish between different TCC subgroups with distinct prognoses.
  • To investigate genetic changes associated with tumor development and progression in TCC.

Main Methods:

  • Review of existing literature on TCC classification and clinical behavior.

Related Experiment Videos

  • Analysis of genetic studies focusing on oncogenes and tumor-suppressor genes in human cancers.
  • Exploration of molecular profiling techniques for identifying TCC subgroups.

    • Main Results:

    • TCCs exhibit distinct clinical forms, with invasive tumors at presentation correlating with poor prognoses.
    • Superficial TCCs, while often curable with local therapies, carry a risk of progression to invasive disease.
    • Genetic alterations are increasingly recognized as key determinants of TCC behavior and progression.

    Conclusions:

    • Understanding the genetic landscape of TCC is essential for accurate prognostication and personalized treatment strategies.
    • Molecular subtyping of TCCs holds promise for identifying tumors likely to progress or respond to specific therapies.
    • Further research into oncogenes and tumor-suppressor genes in TCC is warranted to improve patient outcomes.